Shannon M Conley Selected Research

Shannon M Conley Research Topics

Disease

29	Retinal Degeneration 07/2023 - 01/2009
11	Retinitis Pigmentosa (Pigmentary Retinopathy) 07/2023 - 01/2009
8	Retinal Diseases 01/2021 - 01/2010
6	Macular Degeneration (Age-Related Maculopathy) 07/2023 - 02/2010
4	Hypertension (High Blood Pressure) 02/2024 - 01/2019
4	Blindness (Hysterical Blindness) 01/2022 - 09/2010
3	Cone-Rod Dystrophies 10/2020 - 01/2016
2	Hypertrophy 01/2024 - 01/2019
2	Cognitive Dysfunction 01/2024 - 01/2019
2	Inflammation (Inflammations) 09/2021 - 10/2004
2	congenital stationary Night blindness 01/2016 - 06/2015
2	Stargardt Disease 01/2016 - 09/2012
2	Glaucoma 04/2006 - 02/2004
1	Microvascular Rarefaction 01/2024
1	Atrophy 01/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022
1	Scotoma (Scintillating Scotoma) 01/2022
1	Cochlear Diseases 01/2021
1	Phototoxic Dermatitis (Phototoxicity) 01/2020
1	Cerebral Hemorrhage 01/2019
1	Night Blindness (Nyctalopia) 01/2016
1	Hypoxia (Hypoxemia) 01/2016
1	Vitelliform Macular Dystrophy 04/2013
1	Hyperglycemia 01/2013
1	Microaneurysm 01/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2013
1	Enhanced S-Cone Syndrome 01/2013
1	Ocular Hypertension (Glaucoma, Suspect) 04/2006
1	Starvation 10/2005

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2020 - 02/2010
11	TetraspaninsIBA 07/2023 - 01/2010
10	PeripherinsIBA 10/2020 - 06/2014
7	Retinaldehyde (Retinal)IBA 01/2022 - 01/2013
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2005
4	Rhodopsin (Visual Purple)IBA 10/2020 - 06/2015
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2024 - 01/2019
3	Glycoproteins (Glycoprotein)IBA 01/2016 - 01/2010
2	Angiotensin IIIBA 02/2024 - 01/2019
2	riboflavin-binding proteinIBA 10/2020 - 01/2020
2	Codon (Codons)IBA 01/2016 - 02/2010
2	AntioxidantsIBA 01/2016 - 10/2014
2	DisulfidesIBA 12/2010 - 03/2009
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2010 - 03/2009
2	SeleniumIBA 04/2006 - 02/2004
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2024
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	tyrosine O-sulfateIBA 09/2021
1	Flavin-Adenine Dinucleotide (FAD)IBA 10/2020
1	Flavin Mononucleotide (FMN)IBA 10/2020
1	Riboflavin (Vitamin B2)FDA LinkGeneric 10/2020
1	FlavinsIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2019
1	ElastinIBA 01/2019
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	LipidsIBA 01/2018
1	PolylysineIBA 01/2018
1	Cyclic Nucleotide-Gated Cation ChannelsIBA 03/2016
1	Free RadicalsIBA 01/2016
1	Catalytic RNA (Ribozymes)IBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	SNARE Proteins (SNAREs)IBA 01/2015
1	yttria (yttrium oxide)IBA 10/2014
1	Retinal Pigments (Pigments, Visual)IBA 06/2014
1	Mutant Proteins (Protein, Mutant)IBA 12/2013
1	Cysteine (L-Cysteine)FDA Link 12/2010
1	OpsinsIBA 04/2010
1	Interleukin-10 (Interleukin 10)IBA 10/2004
1	Matrix Metalloproteinases (MMPs)IBA 02/2004

Therapy/Procedure

6	Therapeutics 01/2022 - 04/2010
1	Intravitreal Injections 09/2021